delivery type mark
সারা বাংলাদেশ থেকে অর্ডার করা যাবে।

Supotaria 0.20.2mg/ml

Injection
rx_reqRequire Prescription
Incepta Pharmaceuticals Ltd.
Generic: Glycopyrronium bromide (Glycopyrrolate) Inj
recently bought1891 people recently viewed this.
Best Price
45.00
MRP
50.00
10% OFF

Additional Offers

Show all
Cashback ৳100 : For purchasing above ৳5000+
Cashback ৳80 : For purchasing above ৳4000+
Cashback ৳60 : For purchasing above ৳3000+
Select Language
English
descriptionSafety Advices
AlcoholAlcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Supotaria 0.2. Please consult your doctor.
PregnancyPregnancy
SAFE IF PRESCRIBED
Supotaria 0.2 is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however,... View More
BreastfeedingBreastfeeding
SAFE IF PRESCRIBED
Supotaria 0.2 is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the bab... View More
DrivingDriving
No interaction found/established
KidneyKidney
No interaction found/established
LiverLiver
No interaction found/established
descriptionMedical Overview

Introduction

Supotaria 0.2 is used to treat Chronic obstructive pulmonary disease (COPD). This medicine helps the muscles around the lungs to stay relaxed and reduce... View More

Uses of Supotaria 0.2

  • Chronic obstructive pulmonary disease (COPD)

Side effects of Supotaria 0.2

Common
  • Runny nose
  • Sore throat
  • Upper respiratory tract infection

How to use Supotaria 0.2

Take this medicine in the dose and duration as advised by your doctor. Do not chew, crush or break it.

How Supotaria 0.2 works

Supotaria 0.2 is an anticholinergic medication. It works by blocking the activity of a chemical messenger (acetylcholine) in the brain. This helps the m... View More

quick tipsQuick Tips
  • Supotaria 0.2 is used for long-term management of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD).
  • This medicine is for inhalation using a nebuliser only. The solution should not be injected or swallowed.
  • It does not work right away and should not be used to relieve sudden breathing problems.
  • Take the first dose of this medicine under medical supervision as it may cause wheezing or tightening of the airways (bronchospasm) immediately after us... View More
  • Avoid getting this medication into your eyes. It may cause eye pain/irritation, temporary blurred vision, and other vision changes.
  • Inform your doctor if you have difficulty passing urine or have painful urination.
descriptionBrief Description

Indication

In Anesthesia: • As a pre-operative antimuscarinic agent to reduce salivary, tracheobronchial and pharyngeal sections and to reduce the acidity of the... View More

Adult Dose

Parenteral Reduction of secretions Adult: Preoperative: 4 mcg/kg via IM admin 30-60 minutes before procedure. Intraoperative: 0.1 mg via IV admin, r... View More

Child Dose

Parenteral Reduction of secretions Child: Preoperative: IM admin: <2 yr: 4-9 mcg/kg; >2 yr: 4 mcg/kg, dose to be given 30-60 minutes before procedure.... View More

Contraindication

Angle-closure glaucoma; myasthenia gravis (large doses of quaternary ammonium compounds have been shown to block end plate nicotinic receptors); paralyt... View More

Mode of Action

Glycopyrronium bromide is a quarternary ammonium antimuscarinic. It blocks acetylcholine at parasympathomimetic sites and induces smooth muscle relaxati... View More

Precaution

Antimuscarinics should be used with caution (due to increased risk of side effects) in Down’s syndrome, in children and in the elderly. They should al... View More

Side Effect

Anticholinergic symptoms (mydriasis, hyperthermia, tachycardia, cardiac arrhythmia),Dry mouth,Dry skin,Anhidrosis,Flushing,Blurred vision,Cycloplegia,Ph... View More

Interaction

Decreases levodopa effects. Effects may be enhanced by using drugs with antimuscarinic properties or MAOIs concurrently. May antagonise the GI effects o... View More

descriptionDisclaimer

The information provided herein is accurate, updated and complete as per the best practices of the Company. Please note that this information should not... View More

Open in App